Moderna, COVID-19
Health Canada approves Novavax's updated COVID-19 vaccine for fall
Health Canada said Thursday it has authorized Novavax's updated COVID-19 vaccine for those aged 12 years and up.
Moderna Stock Jumps on Canadian Government's Approval of Updated COVID-19 Vaccine
The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last month, the U.S. Food and Drug Administration also gave approval for the vaccine, as well as updated shots from Pfizer ( PFE) and BioNTech ( BNTX ).
COVID-19 2024 fall guide: Everything Canadians should know about new Moderna vaccine, current variants and more
NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in the fall of 2024." The organization recommends a six-month interval between COVID vaccines, "with a minimum of three months from the last dose."
Moderna's updated COVID-19 vaccine approved in Canada
Health Canada has authorized Moderna's updated COVID-19 vaccine to roll out in fall immunization campaigns. The new Spikevax formula targets the KP.2 subvariant, one of the latest offshoots of the Omicron variant of the virus that causes COVID-19.
Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older
SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians
Moderna Shares Rise on Canada Government Approval of Updated Covid-19 Vaccine
Shares of Moderna rose after the company said that the government of Canada authorized its updated Covid-19 vaccine, joining the U.S. in the approval. The stock was up 4.5% at $72.28 in Tuesday afternoon trading, becoming the best performing stock of the S&P 500 and Nasdaq 100. The stock has, however, dropped 26% since the beginning of the year.
Moderna's updated COVID-19 vaccine for 2024-25 approved in Canada
Health Canada authorized Moderna's updated COVID-19 vaccine on Tuesday to roll out in fall and winter immunization campaigns.
Health Canada approves updated Novavax COVID-19 vaccine
Health Canada authorized Novavax’s updated COVID-19 vaccine that protects against currently circulating variants of the virus on Thursday. The protein-based vaccine, called Nuvaxovid, targets the JN.1 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 Omicron subvariant, the agency said in an online update.
BioNTech Is More Than a Covid-19 Stock. It’s Having a Great September.
BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry ...
Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans
Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development budget by about 20% over ...
New COVID-19 and flu shots are here. Can you get them together? Here's what experts say
The latest flu vaccines are now available, and just like the COVID-19 shots, it's recommended to get the flu shot in ...
COVID-19, flu and RSV shots: Do I really need all three?
All flu vaccines for the 2024-25 season will be trivalent, meaning they protect against three different strains of influenza: ...